BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3585587)

  • 21. Role of DNA ploidy analysis in endometrial adenocarcinoma.
    Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
    Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma.
    Schutte B; Reynders MM; Wiggers T; Arends JW; Volovics L; Bosman FT; Blijham GH
    Cancer Res; 1987 Oct; 47(20):5494-6. PubMed ID: 3652050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry.
    Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M
    Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
    Lundin J; Nordling S; von Boguslawsky K; Roberts PJ; Haglund C
    Anticancer Res; 1995; 15(6B):2659-68. PubMed ID: 8669843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significance of DNA content abnormalities in small rectal cancers.
    Heimann TM; Miller F; Martinelli G; Mester J; Kurtz RJ; Szporn A; Fasy T
    Am J Surg; 1990 Feb; 159(2):199-202; discussion 202-3. PubMed ID: 2301713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Flow-cytometric study of aneuploidy and proliferative activity of colonic cancer cells].
    Bychkova NV; Pozharisskiĭ KM
    Vopr Onkol; 1996; 42(5):40-4. PubMed ID: 9064901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA in situ sensitivity to denaturation: a new parameter for flow cytometry of normal human colonic epithelium and colon carcinoma.
    Kunicka JE; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1987 Aug; 47(15):3942-7. PubMed ID: 3607742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA ploidy and proliferation characteristics of bowel polyps analysed by flow cytometry compared with cytology and histology.
    Petrova AS; Subrichina GN; Tschistjakova OV; Rottenberg VI; Weiss H; Jacobasch KH; Streller B; Wildner GP
    Arch Geschwulstforsch; 1986; 56(3):179-91. PubMed ID: 3729680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor DNA content in gallbladder carcinoma.
    Sato Y; Tanaka J; Koyama K; van Gulik TM; Lygidakis NJ; van der Heyde MN
    Hepatogastroenterology; 1993 Aug; 40(4):375-9. PubMed ID: 8406309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ploidies in 22 colorectal cancers using flow cytometry. Reproducibility of the method and results].
    Henry JP; Cornut P; Cosyn JP; Van Cauter J; Ligny G
    Rev Med Brux; 1988 Apr; 9(3):164-8. PubMed ID: 3399761
    [No Abstract]   [Full Text] [Related]  

  • 31. [p21ras expression, DNA ploidy and prognosis in colorectal cancer].
    Wang S; Yu YX; Zhang JQ
    Zhonghua Wai Ke Za Zhi; 1994 Aug; 32(8):480-2. PubMed ID: 7882773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of flow cytometric determination of ploidy as a guide to prognosis in operable rectal cancer: a multivariate analysis.
    Goh HS; Jass JR; Atkin WS; Cuzick J; Northover JM
    Int J Colorectal Dis; 1987 Feb; 2(1):17-21. PubMed ID: 3598327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of flow cytometric DNA analysis in determining prognosis of resectable ductal adenocarcinoma of the pancreas.
    Park CS; Wiebke EA; Sidner RA; Miller GA; Cummings OW; Howard TJ; Fineberg NS; Madura JA
    Am Surg; 1996 Jul; 62(7):609-15; discussion 615-6. PubMed ID: 8651561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms.
    Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H
    Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer.
    Bittard H; Lamy B; Billery C
    J Urol; 1996 Jun; 155(6):1887-91. PubMed ID: 8618280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA aneuploidy in invasive carcinoma of the uterine cervix.
    Kashyap V; Bhambhani S
    Indian J Pathol Microbiol; 2000 Jul; 43(3):265-9. PubMed ID: 11218670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
    Goodman A; Bell DA; Rice LW
    Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA content in cervical neoplasia and its relationship to prognosis.
    Dudzinski MR; Haskill SJ; Fowler WC; Currie JL; Walton LA
    Obstet Gynecol; 1987 Mar; 69(3 Pt 1):373-7. PubMed ID: 3822284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathologic features in rectal cancer treated by local excision and postoperative radiation therapy.
    Minsky BD; Enker WE; Cohen AM; Lauwers G
    Radiat Med; 1995; 13(5):235-41. PubMed ID: 8848558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Budding as a useful prognostic marker in pT3 well- or moderately-differentiated rectal adenocarcinoma.
    Okuyama T; Oya M; Ishikawa H
    J Surg Oncol; 2003 May; 83(1):42-7. PubMed ID: 12722096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.